PUMA BIOTECHNOLOGY, INC. Cash, Uninsured Amount
PUMA BIOTECHNOLOGY, INC. (PBYI) had Cash, Uninsured Amount of $86.70 million as of 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Notes
us-gaap:CashUninsuredAmount · last filed 2018-03-09
- 2017-12-31: Cash, Uninsured Amount $86.70M.
- 2017-09-30: Cash, Uninsured Amount $85.40M.
- 2017-06-30: Cash, Uninsured Amount $85.70M.
- 2017-03-31: Cash, Uninsured Amount $109.40M.
| Period end | Cash, Uninsured Amount |
|---|---|
| 2017-12-31 | $86.70M 10-K · filed 2018-03-09 |
| 2017-09-30 | $85.40M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $85.70M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $109.40M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $199.00M 10-K · filed 2017-03-01 |
| 2016-09-30 | $56.80M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $62.10M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $82.30M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $36.30M 10-K · filed 2016-02-29 |
| 2015-09-30 | $27.80M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $62.20M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $156.80M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $39.70M 10-K · filed 2015-03-02 |
| 2014-09-30 | $29.30M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $56.40M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $164.60M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $44.20M 10-K · filed 2014-03-03 |
| 2013-09-30 | $52.60M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $61.90M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $92.70M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $138.80M 10-K · filed 2013-04-01 |
| 2012-09-30 | $34.20M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $39.72M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |